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Background. Previous volume-based regional homogeneity (ReHo) studies neglected the intersubject variability in cortical folding
patterns. Recently, surface-based ReHo was developed to reduce the intersubject variability and to increase statistical power. The
present study used this novel surface-based ReHo approach to explore the brain functional activity differences between first-
episode, drug-na¨ıve MDD patients and healthy controls. Methods. Thirty-three first-episode, drug-na¨ıve MDD patients and 32
healthy controls participated in structural and resting-state fMRI scans. MDD patients were rated with a 17-item Hamilton Rating
Scale for Depression prior to the scan. Results. In comparison with the healthy controls, MDD patients showed reduced surface-
based ReHo in the left insula.There was no increase in surface-based ReHo inMDD patients.The surface-based ReHo value in the
left insula was not significantly correlated with the clinical information or the depressive scores in the MDD group. Conclusions.
The decreased surface-based ReHo in the left insula in MDD may lead to the abnormal top-down cortical-limbic regulation of
emotional and cognitive information.The surface-based ReHomay be a useful index to explore the pathophysiological mechanism
of MDD.
1. Introduction
Major depressive disorder (MDD) is characterized by cog-
nitive deficits, functional disability, and pervasive negative
feelings, such as sadness, anxiety, dysphoria, anhedonia,
sleep abnormalities, and feelings of worthlessness [1]. MDD
patients have deficits in emotional self-regulation and are
prone to negative emotion bias toward life events [2].
Researchers have used behavioral, neurochemical, and elec-
trophysiological approaches to explore the pathophysiology
of depression, but the mechanisms of pathophysiology are
still unclear.
Most recently, resting-state fMRI (RFMRI) has been
widely used to study the functional brain abnormalities of
MDD, given the highly synchronous nature of spontaneous
low-frequency oscillations (0.01–0.08Hz) in motor cortices
[3]. Of the many RFMRI approaches, regional homogeneity
(ReHo) has attracted substantial attention in research studies.
ReHo employs Kendall’s coefficient of concordance (KCC)
to measure the functional coherence of a given voxel with
its nearest voxels in a voxelwise analysis; it assumes that the
spontaneous neural activity of a given voxel is similar to its
neighbors [4–6]. ReHo reflects the temporal homogeneity of
the regional blood oxygen level dependent (BOLD) signal.
Thus, an abnormal ReHo may be related to changes in
temporal spontaneous neural activity of a certain region [4].
Various studies explored spontaneous brain activity in
MDD with the volume-based ReHo approach. The MDD
group included medicated and unmedicated patients and
showed decreased ReHo mainly in the frontal and limbic
lobes and the basal ganglia [7]. Given that the MDD group
included some medicated patients, the results could not
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exclude a potential medication effect. Two other studies
explored the ReHo in treatment-resistant depression (TRD)
patients and found that TRD patients showed lower ReHo
in the left insula, the superior temporal gyrus, the inferior
frontal gyrus, the posterior fusiform gyrus, the superior
parietal lobule, and the precuneus [8, 9]. In these two studies,
all of the patients were medicated and treatment-resistant;
thus, the medication may have contributed to the results.
Our previous study investigated the ReHo in 15 first-episode,
drug-na¨ıve MDD patients, 15 first-degree relatives, and 15
healthy controls; the results revealed that bothMDD patients
and the first-degree relatives showed decreased ReHo in the
right insula and the left cerebellum [10]. Two other studies
investigated first-episode and drug-na¨ıve MDD patients and
reported decreased ReHo in the left thalamus, the left tem-
poral lobe, the left cerebellar posterior lobe, and the bilateral
occipital lobe [11] and increased ReHo in the fusiform gyrus
and the bilateral superior frontal gyrus in comparison with
healthy controls [12].
These previous ReHo studies on MDD are based on the
3-dimensional volume-based calculation. Although volume-
based activation maps have been used widely to date, this
approach neglected the intersubject variability in cortical
folding patterns. Therefore, some anatomical regions could
not accurately match the same location in the standard tem-
plate. While under the cortical surface space, the anatomical
regions could occupy the same place, reduce the intersubject
variability, and increase statistical power [13–15]. Recently,
a volume-based ReHo computation was transplanted into
a 2-dimensional variant with cortical surface-based fMRI
analysis; the surface-based ReHowas found to havemoderate
to high intersession and intrasession test-retest reliability
[16].
In the present study, using this relatively new surface-
based ReHo approach, we aimed to explore whether the
surface-based ReHo could be an effective biomarker ofMDD.
We recruited first-episode and drug-na¨ıve patients to exclude
a potential medication effect. Moreover, we also aimed to
investigate the relationships between the ReHo and the
clinical variables in the MDD group.
2. Methods
2.1. Participants. Thirty-two patients with MDD from 17 to
60 years of age were recruited from the inpatient and outpa-
tient units in the Department of Psychiatry, First Hospital of
ShanxiMedical University. All of the patients were diagnosed
with a Chinese version of the Modified Structured Clinical
Interview for DSM-IV for patient version (SCID-I/P) [17]
by two trained clinical psychiatrists. All MDD patients were
drug-na¨ıve and in their first episode of illness (the first time
they experienced a depressive episode).These patients had no
history of othermajor psychiatric illness, neurological illness,
head injury, and alcohol or drug abuse. MDD patients were
rated with a 17-item Hamilton Rating Scale for Depression
(HRSD) before the imaging scan.
Thirty-three age-, gender-, and education-matched
healthy controls were recruited by advertisements. They
were interviewed with the Structured Clinical Interview for
DSM-IV for nonpatient version (SCID-I/NP). All healthy
controls were free of depression or other psychiatric or
neurological illness and had no history of head injury and
alcohol or drug abuse.
All MDD patients and healthy controls were right-
handed. Written informed consent was obtained from each
participant. The Medical Research Ethics Committee of the
First Hospital of Shanxi Medical University approved this
study.
2.2. Data Acquisition. Participants were scanned by the 3.0T
Siemens Trio scanner. During the scanning, participants laid
supine in the scanner with their heads fixed with foam pads
to decrease head motion and reduce scanner noise. They
were informed to close their eyes and remain awake while
moving as little as possible. The scanning sessions included
the following: (i) three-dimensional T1-weightedwhole-brain
images: 3D-MPRAGE sequence, TR/TE = 2300/2.95ms, 160
slices, thickness/gap = 1.2/0.6mm, FOV = 226 × 240mm,
matrix = 240 × 256, and flip angle = 9∘ and (ii) the resting-
state fMRI image: echo planar imaging (EPI) pulse sequence,
32 slices, TR/TE = 2000/30ms, thickness/gap = 3/1mm,
matrix = 64 × 64, FOV = 240 × 240mm, flip angle = 90∘, and
212 volumes.
2.3. Data Preprocessing. The Connectome Computation Sys-
tem (CCS: http://lfcd.psych.ac.cn/ccs.html) carries all steps
of preprocessing both the structural and functional image
preprocessing [16]. The structural image processing included
the following steps: (1) the MR image denoise with a spatially
adaptive nonlocal means filter [18, 19], (2) reconstruction of
cortical surface, (3) segmentation of the cerebrospinal fluid
(CSF), whitematter (WM), and graymatter (GM) volumetric
structures, (4) estimation of a triangular mesh tessellation
over the GM-WM boundary and the mesh deformation to
produce a smooth representation of the GM-WM interface
(white surface) and the GM-CSF interface (pial surface) spa-
tial normalization from individual native space to fsaverage
stereotaxic space, (5) correction of topological defect on the
surface, (6) inflation of individual surface mesh into a sphere,
and (7) estimation of the deformation between the resulting
spherical mesh and a common spherical coordinate system.
The functional image preprocessing included (1) drop of the
first five volumes, (2) slice timing correction, (3) 3D motion
correction, (4) 4D global mean-based intensity normaliza-
tion (mean intensity: 10,000), (5) nuisance regression (the
WM and CSF mean time series and the Friston-24 motion
time series) [20], (6) band-pass filtering (0.01–0.1Hz), (7)
removal of linear and quadratic trends, (8) coregistration
between individual structural and functional images by the
GM-WM boundary-based registration (BBR) algorithm [21],
and (9) projection of the individual preprocessed 4D RFMRI
time series onto a standard cortical surface fsaverage5.
Following the preprocessing, a data quality control
procedure (QCP) was conducted. The QCP of structural
images included visual head motion inspection, tissue
segmentation, and pial and white surface reconstruction.
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The QCP of functional images included steps of check-
ing of the minimal cost of coregistration (mcBBR) and
the root mean square of framewise displacement (rmsFD)
http://lfcd.psych.ac.cn/ccs/QC.html.
2.4. Surface-Based ReHo Analysis. Surface-based ReHo anal-
ysis was performed with the CCS. Details of the analysis
can be found in our recent study [16]. The individual
preprocessed R-FMRI data was projected into the fsaverage5
(FREESURFER 5.1) surface space. For each vertex of the
surface space, the corresponding coordinates were computed
in anatomical and functional space, and then the trilinear
interpolation was used to interpolate the fMRI values [16].
Surface-based ReHo was calculated by Kendall’s coefficient
of concordance of the time series of a given vertex with
those of its nearest neighbors. This computational procedure
was repeated for all vertices in surfaces of both hemispheres
to produce vertexwise KCC-ReHo surface maps, which are
denoted 2-dimensional ReHo (2dReHo). When 7 nearest
neighbors were used to explore the 2dReHo, we call it
2dReHo. Moreover, we also used a broader range of 19
neighbors to calculate 2dReHo and named it 2dReHo2. The
individual 2dReHo maps were smoothed with a Gaussian
kernel of 6mm full-width half-maximum for subsequent
statistical analyses.
2.5. Statistical Analysis. Unpaired two-sample 𝑡-tests were
performed to compare age and years of education. A chi-
square test was used to compare the gender ratio between the
two groups. Voxelwise one-way ANCOVA tests (covariates:
age, sex, years of education, mcBBR, and rmsFD) were per-
formed to explore the 2dReHo differences between theMDD
and healthy controls. The Pearson correlation coefficients
between each vertex on the surface and demographic and
clinical variables were calculated.We employed a cluster-level
familywise error (FWE) correction for multiple comparisons
[22]. Specifically, given a vertexwise statistical parameter
map, a vertexwise 𝑃 value (i.e., uncorrected 𝑃 < 0.01) was
first assigned to form clusters across the entire hemisphere.
Based upon the distribution of spatial extents of the survived
clusters, an implicit cluster size or extent was generated to
achieve the final corrected 𝑃 value (here, 𝑃 < 0.05) for
controlling the FWE.
3. Results
3.1. Participants. Participants’ characteristics are shown in
Table 1. The two groups were matched by age, gender ratio,
and years of education. Moreover, age at illness onset, illness
duration, andHRSD score ofMDD patients are also included
in Table 1.
3.2. Surface-Based ReHo Differences between MDD and
Healthy Controls. Across the cortical surface, no signifi-
cant differences were found between the MDD patients
and healthy controls for the global mean ReHo or ReHo2
(Table 1). Moreover, MDD patients had a significant decrease
in ReHo and ReHo2 in the left insula when compared with
healthy controls (Figure 1).There was no increase in ReHo or
ReHo2 in MDD patients.
3.3. Correlation Analysis. For MDD group, there were no
significant correlations between age/years of education with
left insula ReHo values (age: 𝑃 = 0.26 and 𝑃 = 0.26 for
ReHo and ReHo2; years of education: 𝑃 = 0.81 and 𝑃 =
0.68 for ReHo and ReHo2, resp.). Moreover, no significant
correlations were found between the left insula ReHo values
and the patients’ age at illness onset (𝑃 = 0.24 and 𝑃 = 0.25),
illness duration (𝑃 = 0.90 and 𝑃 = 0.99), or the HRSD total
score (𝑃 = 0.41 and 𝑃 = 0.43).
We also calculated the correlations between global ReHo
values and the age and years of education. For MDD group,
no significant correlations were found between age/yeas of
education and global ReHo values (age: 𝑃 = 0.36 and 𝑃 =
0.44 for ReHo and ReHo2; years of education: 𝑃 = 0.43 and
𝑃 = 0.40 for ReHo and ReHo2). For healthy control group,
there were also no significant correlations between age/years
of education and global ReHo values (age: 𝑃 = 0.25, 𝑃 = 0.29
for ReHo and ReHo2; years of education: 𝑃 = 0.72, 𝑃 = 0.72
for ReHo and ReHo2).
4. Discussion
To the best of our knowledge, this is the first study of
surface-based ReHo in MDD. The present results reveal that
MDDpatients show decreased surface-based ReHo in the left
insula; no significant correlations were found between the
surface-based ReHo value in the left insula and the clinical
characteristics of MDD.
The present surface-based ReHo results are more con-
cise and partly supported by previous volume-based ReHo
studies in MDD [8, 10]. Our previous volume-based ReHo
study found that first-episode, drug-na¨ıve MDD patients had
decreased volume-based ReHo in the right insula cortex
[10]. Different approaches may be the main reason for the
differences across studies. Moreover, the participants and
the scanning parameters were also different. The present
results are supported by a recent meta-analysis of resting-
state brain activity inMDD [23].This meta-analysis included
resting-state fMRI studies analyzed by volume-based ReHo
and independent component analysis, as well as several PET
studies of MDD; the results revealed that MDD patients had
lower brain activity in left insula in comparison with healthy
controls [23].
Located among the frontal, temporal, and parietal lobe
and limbic regions, insula cortex is considered as an inte-
gration center of external events and internal cognitive
processing [24, 25] and plays important role in various
emotional and cognitive functions [26]. Compared with
healthy controls, MDD patients had decreased activation
in the left insula in a series of emotion-related tasks [27–
29]. Recent RFMRI studies also reported decreased func-
tional connectivity between the left insula and the bilateral
amygdala [30] and the insula cortex and the subgenual
anterior cingulate cortex [31] in MDD patients. Another
RFMRI study further revealed that nonrefractory depression
4 BioMed Research International
Table 1: Participants information.
MDD (𝑁 = 33) Health control (𝑁 = 32) 𝑃
Age (years) 34.18 (10.96) 34.56 (9.92) 0.88a
Gender (male/female) 13/20 13/19 0.92b
Yeas of education 13.18 (3.09) 13.72 (2.93) 0.48a
Illness onset age 33.91 (10.92)
Illness duration (month) 6.02 (6.25)
HRSD 20.16 (3.22)
mcBBR 0.59 0.60 0.82a
rmsFD (mm)c 0.14 0.14 0.55a
Global ReHo 0.67 0.66 0.51a
Global ReHo2 0.52 0.52 0.63a
MDD: major depressive disorder; HRSD: Hamilton Rating Scale for Depression. The values in brackets are standard deviations.
aObtained by two-sample 𝑡-test. bObtained by chi-square test; crmsFD is the root mean square of the framewise displacement for in-scanner head motion.
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Figure 1: MDD patients showed lower vertexwise functional homogeneity in left insula ((a) 2dReHo and (b) 2dReHo2) compared to healthy
controls.
was associated with decreased functional connectivity in the
limbic-striatal-pallidal-thalamic circuits, of which the insula
is an important part [32]. A recent meta-analysis focusing
on cortical-subcortical interactions in emotion demonstrated
that the insula is activated across all basic and social emotions
[33]. Two other reviews also highlighted the insula as an
important region involved in emotional processing and the
affective symptoms in MDD [34, 35]. Following a systematic
review of the role of the insula cortex in MDD, researchers
proposed that, due to the neuroanatomical connections, the
insula might also be part of the frontolimbic network [36];
this network plays a very important role in emotion regu-
lation. The decreased activity in the insula cortex of MDD
may lead to somatic complaints, emotional dysfunctions,
and the negative bias in explaining life events [31]. The
abnormal activity of the corticolimbic network leads to the
disruptions of top-down processing, which is thought to
mediate pervasive emotions of sadness and negative affect in
MDD patients.
Recent neuroanatomical and neurochemical studies
reveal that the insula cortex plays an important role in the
pathophysiology of MDD. MDD patients show significantly
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reduced volume [37] and cortical thickness [38] in the
insula cortex. A voxel-based morphometry meta-analysis
supports evidence that the clinical high-risk populations
for psychosis show reduced gray matter in the left insula
[39]. MDD patients also show lower fractional anisotropy
in the left insula compared to healthy controls [40]. Several
positron emission tomography (PET) studies found that
MDD patients showed increased 5-HTT binding potential
[41], decreased binding of the metabotropic glutamate recep-
tor [42], and lower rCBF levels [43] in the insula cortex
compared to healthy controls.
The correlation analysis shows that the surface-based
ReHo value in the left insula cortex was not significantly
correlated with the clinical variables and the depressive
symptoms. Of the previous volume-based ReHo studies in
MDD, only one study reported correlations between the
ReHo value in the right insula and the severity of anxiety
[7]; several other studies did not find significant correlations
between the ReHo values and the clinical variables, as well
as the HRSD score in first-episode and drug-naı¨ve MDD
[10], early-onset and late-onset drug-naı¨ve MDD [12], TRD
[8], and late-life depression [44]. The structural imaging
studies also provided inconsistent results. No significant
correlations were found between insula volume and the
severity of depressive symptoms [37], while significant corre-
lations were reported between the insula cortex and the Beck
Depression Inventory, theHamiltonDepression Rating Scale,
and the Snaith-Hamilton Pleasure Scale in MDD patients
[45]. Together with these correlation results, the correlations
between the ReHo values in the potential biomarker regions
and the depressive symptoms still require further exploration.
Although the present study focused on the surface-based
ReHo, we also analyzed the volume-based ReHo in the
same cohort of participants. With the same covariates (age,
sex, years of education, mcBBR, and rmsFD) and the same
statistical criteria (corrected, 𝑍 = 2.3, 𝑃 < 0.05), we found
no significant clusters between MDD and healthy controls
with volume-based ReHo approach. Some technical and
methodological reasonsmay result in the differences between
surface- and volume-based ReHo approaches. Firstly, the
volume-based ReHo measures local signal synchronization
in both gray and white matter, while the surface-based
ReHomeasures mostly the gray matter local synchronization
signals.Therefore, the volume-based ReHomay include some
artificial signals from white matter. Secondly, for 2dReHo
and 3dReHo, although we try to keep the same length of
neighbors for a certain vertices or voxel, the number of
neighbors is different; the 2dReHo1 and 2dReHo2 calculation
recruits 6 and 19 neighbors, respectively, while the 3dReHo
recruits 26 neighbors. Moreover, the mask templates are
different (MNI 152 3mm standard volume for 3dReHo, while
fsaverage5 4mm resolution standard space for 2dReHo).
These factors may influence the results in some degree.
Thirdly, on the cortical surface, the intersubject variability
in anatomy and the intersubject registration in both brain
structure and function may be estimated more accurately
[16]. Finally, previous volume-based neuroimaging studies
consider that some subcortical regions (amygdala and tha-
lamus) play important role in emotional circuit [46, 47];
however, the present surface-based ReHo only investigates
the cortical regions; therefore it cannot reveal the differences
in subcortical regions between healthy controls and MDD.
Although the present surface-based ReHo revealed
interesting results, this study also had several limita-
tions. First, previous findings suppose that MDD patients
show deficits in the prefrontal-amygdala-pallidostriatal-
mediothalamic mood regulating circuit [46, 47]. Given that
the present surface-based ReHo approach focuses only on the
cortical cortex, we did not examine the surface-based ReHo
in the subcortical cortex, which are important regions of the
mood regulating circuit. Second, the present study did not
include neuropsychological tasks, specifically, the emotion
processing related tasks. Including these tasks may help
to determine whether the first-episode, drug-naı¨ve MDD
patients show deficits in the corresponding behavioral levels.
In conclusion, the present study revealed decreased
surface-based ReHo in the left insula in MDD patients. The
abnormal activity in the left insula may lead to the abnormal
top-down cortical-limbic regulation of the emotional and
cognitive based information. Moreover, no significant corre-
lations were found between the surface-based ReHo value in
the left insula and the age, years of education, age of illness
onset, illness duration, and HRSD score in MDD patients.
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